Ivaril LS Syrup Strawberry is a combination expectorant and bronchodilator formulation containing Ambroxol (30mg/5ml), Levosalbutamol (1mg/5ml), and Guaifenesin (50mg/5ml). Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing smooth muscles of the bronchial airways, which helps alleviate bronchospasm and improve airflow in obstructive airway conditions. Guaifenesin serves as an expectorant, promoting the thinning and loosening of mucus, enhancing its expulsion through coughing. This synergistic combination is indicated for the symptomatic relief of respiratory conditions associated with excessive or thick mucus production and bronchoconstriction, such as acute and chronic bronchitis, asthma, and other obstructive pulmonary diseases. The strawberry-flavored syrup formulation ensures palatability, improving patient compliance, especially in pediatric populations. Ivaril LS Syrup should be used under medical supervision, with dosage adjusted according to age and clinical condition. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. Adverse effects may include mild gastrointestinal disturbances, tremors, or tachycardia.